Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Glaukos Corporation
The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery compared to cataract surgery only, in subjects with mild to moderate open-angle glaucoma.
Age
22–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
mild to moderate primary open-angle glaucoma
currently treated with ocular hypotensive medication
pseudoexfoliative and pigmentary glaucoma are acceptable diagnoses
subject scheduled to undergo cataract surgery
You may not be if
primary angle-closure glaucoma; or secondary angle closure glaucoma, including neovascular glaucoma
retrobulbar tumor, thyroid eye disease, Sturge-Weber syndrome or any other type of condition that may cause elevated episcleral venous pressure
Clareo Health | Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
